Enjoy complimentary customisation on priority with our Enterprise License!
The hepatocellular carcinoma treatment market share is expected to increase by USD 106.48 million from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 4.1%.
This hepatocellular carcinoma treatment market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers hepatocellular carcinoma treatment market segmentation by therapy (chemotherapy, brachytherapy, and ablation therapy) and geography (North America, Europe, Asia, and ROW). The hepatocellular carcinoma treatment market report also offers information on several market vendors, including AbbVie Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol-Myers Squibb Co., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Johnson & Johnson, and Pfizer Inc. among others.
Download Report Sample to Unlock the Hepatocellular Carcinoma Treatment Market Size for the Forecast Period and Other Important Statistics
The growing prevalence of lifestyle diseases is notably driving the hepatocellular carcinoma treatment market growth, although factors such as high side effects of the available therapies, especially chemotherapy drugs may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the hepatocellular carcinoma treatment industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Hepatocellular Carcinoma Treatment Market Driver
The growing prevalence of lifestyle diseases is one of the major drivers of the hepatocellular carcinoma treatment market growth. Lifestyle diseases such as diabetes, obesity, and high blood pressure have a huge effect on the liver and are some of the major causes of hepatocellular carcinoma. The rising incidence of lifestyle diseases will augment the demand for hepatocellular carcinoma treatment. Non-alcoholic fatty liver disease (NAFLD), is one of the major types of liver disease. According to the NIH, 20%-30% of the general population in Western countries suffer from NAFLD. Also, the prevalence rate of NAFLD increases in people with type 2 diabetes (70%) and obesity (90%). As hepatocellular carcinoma is highly influenced by the prevalence of NAFLD, if left untreated, such a high prevalence of lifestyle diseases will ultimately boost the hepatocellular carcinoma treatment market. Lifestyle disease associated with hepatocellular carcinoma
Key Hepatocellular Carcinoma Treatment Market Trend
An increase in R&D activities for liver cirrhosis medication is one of the major trends for the hepatocellular carcinoma treatment market growth. The need for efficacious and better-tolerated medications drives R&D in the global liver cirrhosis medication market. The growing incidence of the disease represents significant opportunities for market growth. Companies are working toward the development of drugs that cater to the unmet medical needs of this condition. For instance, Stempeucel by Stempeutics Research and Rifaximin SSD by Valeant Pharmaceuticals is in the Phase II stage of development for the treatment of liver cirrhosis. Similarly, Adipose-derived stem cells by Gwo Xi Stem Cell Applied Technology are in the Phase I stage of development. Apart from this, molecules are also present in the preclinical and discovery stages, forming a strong pipeline for liver cirrhosis. The launch of drug candidates, which are currently in the late developmental stage, will contribute to the market's growth.
Key Hepatocellular Carcinoma Treatment Market Challenge
High side effects of the available therapies, especially chemotherapy drugs are one of the major challenges for the hepatocellular carcinoma treatment market growth. Severe side-effects of liver disease treatment drugs reduce patient compliance and might also result in patient dropouts, which, in turn, decreases the demand for the drugs, thus reducing their sales. These drugs are available in multiple dosage forms and combinations. Some common side effects are dry mouth, constipation, dry eyes, vision impairment, urinary tract infections, alopecia, urine retention, and drowsiness. Precaution must be taken when administering these drugs to elderly patients with cognitive impairment or dementia, as the drugs may worsen their symptoms. Although these drugs are used in children an extra dose of these drugs that are beyond the permissible limit can cause serious side effects. The most commonly reported side effects associated are headaches and urinary tract infections. Some rarely occurring side effects are heart palpitation, abdominal pain, diarrhea, rash, and constipation. Therefore, the potential side effects of hepatocellular carcinoma drugs impede the rationale for the use of these drugs for the treatment of hepatocellular carcinoma, which negatively impacts the growth of the market
This hepatocellular carcinoma treatment market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Technavio categorizes the hepatocellular carcinoma treatment market as a part of the pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the hepatocellular carcinoma treatment market during the forecast period.
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
This statistical study of the hepatocellular carcinoma treatment market encompasses successful business strategies deployed by the key vendors. The hepatocellular carcinoma treatment market is fragmented and the vendors are deploying growth strategies such as strategic collaboration to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The hepatocellular carcinoma treatment market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the hepatocellular carcinoma treatment market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the pharmaceuticals market includes the following core components:
The report has further elucidated other innovative approaches being followed by manufacturers to ensure a sustainable market presence.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Therapy
6 Customer landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.